Skip to main content
Diseases

2型糖尿病 (T2D)

About this disease

Disease classification:endocrine pancreas disorder; pancreas disorder; glucose metabolism disease; digestive system disorder; diabetes mellitus; metabolic disease

A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.

Standard definition source:MONDO:0005148 type 2 diabetes mellitus · ontology version 2026-10-06

Applicable models (published, verified)

  • db/db (Lepr^db) · db/db 模型用于肥胖相关胰岛素抵抗和2型糖尿病研究,适用性受遗传背景影响。 · Verified applicability
  • ob/ob (Lep^ob) · ob/ob 模型用于肥胖、胰岛素抵抗与2型糖尿病相关代谢研究,糖尿病表型受遗传背景影响。 · Verified applicability
  • CC G×E 多品系队列 (NZO 背景) · CC多品系在饮食条件下与T2D相关的体重、葡萄糖代谢及宿主遗传背景互作的文献参考用途。所引研究使用CC037、CC019、CC010、CC005及C57BL/6对照;其结果不据此证明本条所称“NZO背景”队列的具体组成或公司资源身份。 · Verified applicability
  • 饮食诱导肥胖(DIO)模型(文献参考) · 2型糖尿病饮食诱导肥胖与胰岛素抵抗研究的文献参考模型(DIO) · Verified applicability
  • high-fat diet-fed C57BL/6J mouse · HFD group compared with chow-fed controls for metabolic and renal outcomes. · Verified applicability
  • Wistar fatty rat · Wistar fatty rats develop glucose intolerance accompanied by exaggerated insulin secretion, hypertrophied islets with degranulation of β cells, albuminuria and decreased GFR, increased ICAM-1 expression and renal hypertrophy. · Verified applicability
  • high-fat diet plus low-dose streptozotocin-induced type 2 diabetes rodent · How can diet and low-dose streptozotocin be combined to model type 2 diabetes?; rodents fed high caloric diets with low-dose STZ · Verified applicability
  • Zucker diabetic Sprague-Dawley (ZDSD) rat · Which rodent models and endpoints have been used to study obesity, type 1 diabetes, type 2 diabetes and diabetic peripheral neuropathy, and what are their limitations?; Zucker diabetic Sprague-Dawley rats. · Verified applicability
  • ob/ob C57BL/6 mouse · The review evaluates monogenic obesity models for T2D.; Published ob/ob mouse studies. · Verified applicability
  • Goto-Kakizaki rat · Does resveratrol improve glucose tolerance, tissue lipid handling and pancreatic islet structure in Goto-Kakizaki rats?; GK rats · Verified applicability
  • db/db C57BLKS mouse · Which renal and metabolic abnormalities develop in db/db mice; db/db mouse kidney and urine at 12 weeks · Verified applicability
  • high-fat diet plus low-dose streptozotocin-induced type 2 diabetes C57BL/6J mouse · How chromatin accessibility, transcript isoforms and RNA modifications are remodeled in diabetic cardiomyopathy.; Whether HFD/STZ mice develop diabetic cardiomyopathy with transcriptional and epigenetic remodeling. · Verified applicability
  • high-fat diet plus streptozotocin-induced type 2 diabetes C57BL/6J mouse · Does aerobic exercise alleviate diabetic arterial remodeling through Sirt1?; Male C57BL/6J mice, 6 weeks old; CON, CON-Exe, T2DM and T2DM-Exe groups · Verified applicability
  • university of california davis type 2 diabetes mellitus UCD-T2DM rat · How is diabetes defined and staged in the UCD-T2DM rat?; UCD-T2DM rats under regular chow or high-fat diet, with fed or fasting blood glucose monitoring. · Verified applicability
  • high-fat diet plus streptozotocin-induced type 2 diabetes C57BL/6 mouse · Does the STZ-HFD model produce more intervertebral disc inflammation and degeneration than db/db?; Intervertebral discs from male C57BL/6 mice, 12 weeks old at start, n=13 STZ-HFD and n=7 vehicle controls · Verified applicability
  • ob/ob mouse · Does suppressing Lpcat3 improve insulin resistance and lipid metabolism in diet-induced and genetic obese diabetic mice?; 6-7-week-old ob/ob mice · Verified applicability
  • high-fat diet-induced obesity mouse · Whether PTPN1/PTPN2 inhibition induces weight loss in diet-induced obesity with an intact but resistant leptin axis; DIO mice, n = 5 per group, 6-week treatment plus 2-week withdrawal · Verified applicability
  • Otsuka Long-Evans Tokushima Fatty (OLETF) rat · Recommendation that diabetic rat models remain essential for developing novel drugs and understanding human diabetes.; Review-level conclusion. · Verified applicability
  • Spontaneously Diabetic Torii (SDT) rat · Which rat model most closely resembles human DR pathophysiology?; Review of spontaneously diabetic Torii rats · Verified applicability
  • t2dn/mcwi rat · Is the T2DN/Mcwi rat suitable for advanced diabetic nephropathy research?; T2DN/Mcwi rat · Verified applicability
  • Spontaneously Diabetic Torii (SDT) fatty rat · Pathophysiological features of diabetes and its complications in obese T2D rat models.; Review-level synthesis across models. · Verified applicability
  • KK-Ay mouse · What stages of diabetic nephropathy does the KK-Ay mouse reproduce?; KK-Ay mouse · Verified applicability
  • ob/ob BTBR mouse · Which rodent models and phenotyping methods are appropriate for experimental diabetic nephropathy?; diabetic nephropathy models · Verified applicability
  • high-fat diet plus low-dose streptozotocin-induced type 2 diabetes Wistar rat · Does MOTS-c restore cardiac mitochondrial respiration in type 2 diabetic rats?; Male Wistar rats, 6-7 weeks old and 150-200 g, fed a high-fat diet for 15 weeks with a 25 mg/kg streptozotocin injection at week 8 · Verified applicability
  • Zucker diabetic fatty (ZDF) rat · Review of pancreatic, renal, ocular, neural, bone and gonadal complications in obese T2D rat models.; Review-level synthesis of ZDF studies. · Verified applicability
  • db/db mouse · Which metabolic and renal abnormalities develop in db/db mice; kidney tissue, urine and serum from db/db mice · Verified applicability
  • high-fat diet-induced obesity and diabetes C57BL/6J mouse · Does liver-directed AAV-BMP7 reverse diet-induced obesity and insulin resistance?; Male C57BL/6J mice fed chow or HFD for 6 weeks from 2 months of age, then followed about 6 months · Verified applicability
  • high-fat diet plus low-dose streptozotocin-induced type 2 diabetes Sprague-Dawley rat · Whether DMT1-mediated iron transport in bone contributes to the bone microstructure and biomechanical deterioration of type 2 diabetic osteoporosis.; Tibia of male Sprague-Dawley rats, 3 months old at purchase, fed high-fat diet for two months then given 30 mg/kg intraperitoneal streptozotocin, studied at 8 months of age; n=10 per group. · Verified applicability
  • High-fat diet-fed C57BL/6 mouse · Does loss of CD226 alter high-fat diet-induced obesity and adipose tissue macrophage inflammation?; Wild-type C57BL/6 littermates fed a 60% fat HFD for 16 weeks starting at 5-6 weeks of age · Verified applicability
  • SHR/N-corpulent (SHR/N-cp) rat · How relevant and translatable are leptin- and leptin receptor-deficient rodent models to human type 2 diabetes?; Narrative review of published studies on leptin- and leptin receptor-deficient rodents; no animals used in this study · Verified applicability
  • Tcf7l2 whole-body knockout mouse (reference model) · What whole-body loss of Tcf7l2 reveals about T2D risk gene function.; Constitutive Tcf7l2 −/− mice. · Verified applicability
  • ZnT8 (Slc30a8) systemic knockout mouse · What systemic ZnT8 loss reveals about insulin processing and glucose homeostasis.; Systemic ZnT8 knockout mice from several colonies. · Verified applicability
  • pancreas-specific Tcf7l2 knockout mouse (Pdx1-Cre) · Whether pancreatic Tcf7l2 deletion impairs glucose homeostasis.; Pancreas-specific Tcf7l2 knockout mice. · Verified applicability
  • alpha cell-specific ZnT8 knockout mouse · Whether α cell ZnT8 deletion affects glucose tolerance.; α cell-specific ZnT8 null mice. · Verified applicability
  • beta cell-specific Tcf7l2 knockout mouse (RIP2.Cre-ER T2, tamoxifen-inducible) · Whether β cell-specific Tcf7l2 deletion reproduces the islet phenotype.; βTCF4KO mice on normal or high-fat diet. · Verified applicability
  • beta cell-specific ZnT8 knockout mouse (RIP2 promoter) · Whether β cell ZnT8 deletion accounts for the systemic knockout phenotype.; β cell-specific ZnT8 null mice. · Verified applicability
  • high-fat diet-fed Wistar rat · What hepatic and adipose responses do Wistar rats show to moderate-duration HFD?; Reviewed studies of Wistar rats fed 45% lard-based diet for 4-15 weeks · Verified applicability
  • high-fat diet-induced obesity Sprague-Dawley rat · Which rodent models and endpoints have been used to study obesity, type 1 diabetes, type 2 diabetes and diabetic peripheral neuropathy, and what are their limitations?; High-fat diet-fed Sprague-Dawley rats. · Verified applicability
  • Zucker fatty (fa/fa) rat · Which rodent models and endpoints have been used to study obesity, type 1 diabetes, type 2 diabetes and diabetic peripheral neuropathy, and what are their limitations?; Obese Zucker (fa/fa) rats. · Verified applicability
  • JCR:LA-corpulent (JCR:LA-cp) rat · How relevant and translatable are leptin- and leptin receptor-deficient rodent models to human type 2 diabetes?; Narrative review of published studies on leptin- and leptin receptor-deficient rodents; no animals used in this study · Verified applicability
  • 45% high-fat diet Western-like rodent model · Review-recommended model that most closely recapitulates human Western diet and progressive T2D phenotype · Verified applicability
  • high carbohydrate diet-induced rat model · Review-recommended model for early MS stages with mild FBG effect but significant hypertriglyceridemia and IR · Verified applicability
  • high carbohydrate-high fat diet-induced rat model (cafeteria diet) · Review-recommended cafeteria-style HCH-HFD as the most robust model inducing obesity, dyslipidemia, IR, hyperglycemia and inflammation · Verified applicability
  • high fat diet-induced rat model · Review-recommended 30-50% HFD as the model of choice to simulate a condition close to T2DM within 10+ weeks · Verified applicability
  • neonatal streptozotocin followed by high-fat diet mouse · Streptozotocin-induced diabetes combined with HFD is used as a NAFLD model · Verified applicability
  • high-fat diet plus streptozotocin-induced type 2 diabetes mouse (adult induction) · Adult high-fat diet plus streptozotocin mouse research on hyperglycemia and diabetic kidney injury. · Verified applicability

References

  1. Noshahr Zahra Samadi, Salmani Hossein, Khajavi Rad Abolfazl, Sahebkar Amirhossein. Animal Models of Diabetes-Associated Renal Injury. Journal of Diabetes Research. 2020.
  2. Wang Yun, Zheng Yue, Nishina Patsy M, Naggert Jürgen K.. A new mouse model of metabolic syndrome and associated complications. The Journal of endocrinology. 2009.
  3. Wu Suhua, Peng Juan, Wang Xiaodong, Gao Hong, Fang Huangrui, Hu Shiyi, Wei Qiufen, Dang Yuanye, Tu Haixia, Zhu Mingyan, Peng Jianye, Liu Yumiao, Zeng Gaofeng, Dai Xiaoyan. Gpx4 Deletion‐Mediated Macrophage Ferroptosis Alleviates Obesity‐Associated Insulin Resistance. The FASEB Journal. 2026.
  4. Yorek M.A.. Alternatives to the Streptozotocin-Diabetic Rodent. International review of neurobiology. 2016.
  5. Van Herck Mikhaïl A., Vonghia Luisa, Francque Sven M.. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide. Nutrients. 2017.
  6. Wang Andrea N., Carlos Joselia, Fraser Graham M., McGuire John J.. Zucker Diabetic‐Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model. Experimental Physiology. 2022.
  7. Rodríguez-Correa Eduardo, González-Pérez Imelda, Clavel-Pérez Pedro Isauro, Contreras-Vargas Yolanda, Carvajal Karla. Biochemical and nutritional overview of diet-induced metabolic syndrome models in rats: what is the best choice?. Nutrition & Diabetes. 2020.
  8. He Huijun, Wang Honglian, Chen Xiaocui, Zhong Yu, Huang Xiao Ru, Ma Ronald CW, Wang Cheng, Lan Hui-Yao. Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling. International Journal of Biological Sciences. 2024.
  9. da Silva Xavier Gabriela, Bellomo Elisa A., McGinty James A., French Paul M., Rutter Guy A.. Animal Models of GWAS-Identified Type 2 Diabetes Genes. Journal of Diabetes Research. 2013.
  10. Zhou Rongrong, Llorente Cristina, Cao Jinling, Zaramela Livia S., Zeng Suling, Gao Bei, Li Shang-Zhen, Welch Ryan D., Huang Feng-Qing, Qi Lian-Wen, Pan Chuyue, Huang Yan, Zhou Pengchen, Beussen Iris, Zhang Ying, Bryam Gregory, Fiehn Oliver, Wang Lirui, Liu E-Hu, Yu Ruth T., Downes Michael, Evans Ronald M., Goglin Karrie, Fouts Derrick E., Brenner David A., Bode Lars, Fan Xuegong, Zengler Karsten, Schnabl Bernd. Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice. Cellular and Molecular Gastroenterology and Hepatology. 2021.
  11. Wang Bingxuan, P. Charukeshi Chandrasekera, Pippin John J.. Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes. Current Diabetes Reviews. 2014.
  12. Huang Chien-Wei, Li Chia-Jung, Sung Junne-Ming, Tsai Yau-Sheng, Chen Jin-Shuen. Association between FNDC5 Deficiency and Compromised Mitochondrial Integrity and Biogenesis in Kidney Disease. International Journal of Medical Sciences. 2026.
  13. Heydemann Ahlke. An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2016.
  14. Katsuda Yoshiaki, Ohta Takeshi, Miyajima Katsuhiro, Kemmochi Yusuke, Sasase Tomohiko, Tong Bin, Shinohara Masami, Yamada Takahisa. Diabetic Complications in Obese Type 2 Diabetic Rat Models. Experimental Animals. 2014.
  15. Al Kury L., Smail M., Qureshi M. A., Sydorenko V., Shmygol A., Oz M., Singh J., Howarth F. C.. Calcium Signaling in the Ventricular Myocardium of the Goto-Kakizaki Type 2 Diabetic Rat. Journal of Diabetes Research. 2018.
  16. Kitada Munehiro, Ogura Yoshio, Koya Daisuke. Rodent models of diabetic nephropathy: their utility and limitations. International Journal of Nephrology and Renovascular Disease. 2016.
  17. Islam Md. Shahidul. Animal Models of Diabetic Neuropathy: Progress Since 1960s. Journal of Diabetes Research. 2013.
  18. Feng Bin, Chen Chao, Chen Lin, Chen Yuqiong, Mao Wenjun, Yu Peiran, Yu Hao, Shi Bimin, Zhang Nannan. LGR6 couples maresin 1 signaling to glycolytic flux and protein lactylation for the rescue of diabetic cardiomyopathy. Journal of Diabetes Investigation. 2026.
  19. Pitale Priyamvada M., Gorbatyuk Marina S., Rossi Settimio. Diabetic Retinopathy: From Animal Models to Cellular Signaling. International Journal of Molecular Sciences. 2022.
  20. Stott Nicole L., Marino Joseph S.. High Fat Rodent Models of Type 2 Diabetes: From Rodent to Human. Nutrients. 2020.